20 (AIDX) Research & Development (2025 - 2026)
20's (AIDX) quarterly Research & Development came in at $153482.0 in Q1 2026, up 12.17% YoY from $136831.0 in Q1 2025, and up 12.17% on a QoQ basis from $136831.0 in Q1 2025.
20 (AIDX) Research & Development (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Research & Development data on file, last reported at $153482.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | 20 | 5.50 Mn | 957,128.12 | 304,727.00 | 257,632.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 153,482.00 |
| Mar 31, 2025 | 136,831.00 |